MR imaging characterization of microvessels in experimental breast tumors by using a particulate contrast agent with histopathologic correlation

Radiology

Volumn 218, Issue 2, 2001, Pages 562-569

  Turetschek, K ^a   Huber, S ^a   Floyd, E ^a   Helbich, T ^a   Roberts, T P L ^a   Shames, D M ^a   Tarlo, K S ^a   Wendland, M F ^a   Brasch, R C ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Animals; Breast neoplasmn 00.30; Contrast media; Iron; Magnetic resonance (MR), three dimensional

Indexed keywords

CONTRAST MEDIUM; GADOLINIUM PENTETATE ALBUMIN; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CARCINOMA; BREAST DISEASE; BREAST TUMOR; CONTRAST ENHANCEMENT; FIBROADENOMA; HISTOPATHOLOGY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RAT; TUMOR DIAGNOSIS;

EID: 0035143782     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiology.218.2.r01fe37562     Document Type: Article

References (54)

1. Ultrasmall superparamagnetic iron oxide particles (AMI 227) as a blood pool contrast agent for MR angiography: Experimental study in rabbits
2. Contrast-enhanced 3D-TOF MRA of peripheral vessels: Intravascular versus extracellular MR contrast media
3. Correlation of dynamic contrast-enhanced MR imaging with histologic tumor grade: Comparison of macromolecular and small-molecular contrast media
4. Barriers to drug delivery in solid tumors
5. Contrast-enhanced MR imaging assessment of tumor capillary permeability: Effect of irradiation on delivery of chemotherapy
6. Microvascular permeability of normal and neoplastic tissues
7. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: Experience from a large study with long-term follow-up
8. Tumor angiogenesis and metastasis: Correlation in invasive breast carcinoma
9. Ultrasmall superparamagnetic iron oxide: Characterization of a new class of contrast agents for MR imaging
10. Abdominal vessel enhancement with an ultrasmall, superparamagnetic iron oxide blood pool agent: Evaluation of dose and echo time dependence at different field strengths
11. Safety profile of ultrasmall superparamagnetic iron oxide ferumoxtran-10: Phase II clinical trial data
12. Diverse spectrum of tumors in male Sprague-Dawley rats following single high doses of N-ethyl-N-nitrosurea (ENU)
13. Neoplasms induced with high single doses of N-ethyl-N-nitrosurea in 30 day-old Sprague-Dawley rats, with special emphasis in mammary neoplasia
14. Quantification of liver blood volume: Comparison of ultra short TI inversion recovery echo planar imaging (ULSTIR-EPI), with dynamic 3D-gradient recalled echo imaging
15. Albumin labeled with Gd-DTPA: An intravascular contrast enhancing agent for magnetic resonance blood pool imaging - Preparation and characterization
16. Albumin labeled with Gd-DTPA. An intravascular contrast-enhancing agent for magnetic resonance blood pool and perfusion imaging
17. Comparison of the contrast-enhancing properties of albumin-(Gd-DTPA) and Gd-DTPA at 2.0 T: An experimental study in rats
18. Transport of molecules across tumor vasculature
19. Mechanisms of heterogeneous distribution of monoclonal an tibodies and other macromolecules in tumors: Significance of elevated interstitial pressure
20. Mammary carcinoma model: Correlation of macromolecular contrast-enhanced MR imaging characterizations of tumor microvasculature and histologic capillary density
21. Assessing tumor angiogenesis using macromolecular MR imaging contrast media
22. Contrast-enhanced magnetic resonance imaging estimation of altered capillary permeability in experimental mammary carcinomas after X-irradiation
23. Quantitative dependence of MR signal intensity on tissue concentration of Gd(HP-DO3A) in the nephrectomized rat
24. Measurement of capillary permeability to macromolecules by dynamic magnetic resonance imaging: A quantitative noninvasive technique
25. Histologic grading and prognosis in breast cancer
26. Prognostic value of histologic grade nuclear components of Scarff-Bloom-Richardson (SBR): An improved score modification based on a multivariate analysis of 1262 invasive ductal breast carcinomas
27. Transport of molecules in the tumor interstitium: A review
28. Ultrasmall superparamagnetic iron oxide: An intravenous contrast agent for assessing lymph nodes with MR imaging
29. Use of USPIO-induced magnetic susceptibility artifacts to identify sentinel lymph nodes and lymphatic drainage patterns. I. Dependence of artifact size with subcutaneous Combidex close in rats
30. MRI in focal liver disease: A comparison of small and ultra-small superparamagnetic iron oxide as hepatic contrast agents
31. Contribution of Sinerem used as blood-pool contrast agent: Detection of cerebral blood volume changes during apnea in the rabbit
32. MR angiography with an ultrasmall superparamagnetic iron oxide blood pool agent
33. Albumin-(DTPA-Gd)15-20: Whole body clearance and organ: Distribution of gadolinium
34. In vitro histamine release induced by magnetic resonance imaging and iodinated contrast media
35. Prostate cancer tumor grade differentiation with dynamic contrast-enhanced MR imaging in the rat: Comparison of macromolecular and small-molecular contrast media - Preliminary experience
36. Arthritic temporomandibular joint: Correlation of macromolecular contrast-enhanced MR imaging parameters and histopathologic findings
37. Assessment of acute and reperfused myocardial ischemia using GdDTPA, Gd-DTPA-cascade-24-polymer and albumin-GdDTPA
38. Non-invasive assessment of wound healing angiogenesis with contrast enhanced MRI
39. Pulmonary oxygen toxicity: Demonstration of abnormal capillary permeability using contrast-enhanced MRI
40. MRI of the breast with Gd-DTPA: Use and limitations
41. Identification and characterization of the blood vessels of solid tumors that are leaky to circulating macromolecules
42. Extravascular transport in normal and tumor tissues
43. Differential macromolecular leakage from the vasculature of tumors
44. Pathogenesis of tumor stroma generation: Critical role for leaky blood vessels and fibrin depositions
45. Introduction: Angiogenesis and cancer
46. Vascular endothelium as the vulnerable element in tumours
47. Pathogenesis of ascites tumor growth: Angiogenesis, vascular remodeling, and stroma formation in the peritoneal lining
48. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability and angiogenesis
49. Vascular endothelial growth factor: Basic biology and clinical implications
50. Vascular permeability factor: A unique regulator of blood vessel function
51. Tumor vascular targeted therapies
52. A highly conserved vascular permeability factor secreted by a variety of human and rodent tumor cell lines
53. Hepatic MRI with SPIO: Detection and characterization of focal liver lesions